Cardiovascular Pharmacotherapy

  • Types
  • Formats
  • Years
  • Events
  • Communities
  • Special Options

Showing 24 of 1191 results

Compliance to direct oral anticoagulation therapy and clinical outcomes after catheter ablation for atrial fibrillation: a nationwide cohort study
ESC Journals
Compliance to direct oral anticoagulation therapy and clinical outcomes after catheter ablation for atrial fibrillation: a nationwide cohort study
30 June 2026
See more
Early catheter ablation vs. antiarrhythmic drugs in treatment-naïve ischaemic ventricular tachyarrhythmias: a meta-analysis of randomized controlled trials
ESC Journals
Early catheter ablation vs. antiarrhythmic drugs in treatment-naïve ischaemic ventricular tachyarrhythmias: a meta-analysis of randomized controlled trials
26 June 2026
See more
ST-elevation myocardial infarction following de-escalation to aspirin monotherapy: evidence of residual platelet function MRP4 overexpression dependent case report
ESC Journals
ST-elevation myocardial infarction following de-escalation to aspirin monotherapy: evidence of residual platelet function MRP4 overexpression dependent case report
22 May 2026
See more
Stent thrombosis associated with non-response to clopidogrel despite co-administration of aspirin and ibrutinib
ESC Journals
Stent thrombosis associated with non-response to clopidogrel despite co-administration of aspirin and ibrutinib
21 May 2026
See more
Rifampicin for the treatment of a cardiogenic shock related to mavacamten toxicity: the worse and the best of drug interactions from a case report
ESC Journals
Rifampicin for the treatment of a cardiogenic shock related to mavacamten toxicity: the worse and the best of drug interactions from a case report
14 May 2026
See more
From angiography-derived physiology guided PCI to INOCA treatment and to coronary sinus reducer: navigating multiple pathophysiological targets in a single patient: a case report
ESC Journals
From angiography-derived physiology guided PCI to INOCA treatment and to coronary sinus reducer: navigating multiple pathophysiological targets in a single patient: a case report
14 May 2026
See more
Feasibility of hypnosis for analgosedation during atrial fibrillation ablation, including pulsed field and radiofrequency techniques: a pilot study
ESC Journals
Feasibility of hypnosis for analgosedation during atrial fibrillation ablation, including pulsed field and radiofrequency techniques: a pilot study
14 May 2026
See more
Disturbed flow induced targeting of nanomedicine to endothelial cells for effective atherosclerosis therapy
ESC Journals
Disturbed flow induced targeting of nanomedicine to endothelial cells for effective atherosclerosis therapy
13 May 2026
See more
Heart failure with preserved ejection fraction subtypes: pathophysiology and treatments
Congress Session
Heart failure with preserved ejection fraction subtypes: pathophysiology and treatments
11 May 2026
See more
ePosters in pharmacology and pharmacotherapy (2)
Congress Session
ePosters in pharmacology and pharmacotherapy (2)
11 May 2026
See more
Updates in gene therapy in heart failure and cardiomyopathies
Congress Session
Updates in gene therapy in heart failure and cardiomyopathies
10 May 2026
See more
ePosters in pharmacology and pharmacotherapy (1)
Congress Session
ePosters in pharmacology and pharmacotherapy (1)
10 May 2026
See more
Controversies in contemporary drug therapy for heart failure
Congress Session
Controversies in contemporary drug therapy for heart failure
9 May 2026
See more
Proteins targeting ischaemic-reperfusion injury and repair after myocardial infarction: a systematic literature review
ESC Journals
Proteins targeting ischaemic-reperfusion injury and repair after myocardial infarction: a systematic literature review
7 May 2026
See more
When are beta-blockers safe to use? Symptoms of depression and anxiety in aggregated data of pragmatic open-label trials
ESC Journals
When are beta-blockers safe to use? Symptoms of depression and anxiety in aggregated data of pragmatic open-label trials
22 April 2026
See more
Inhibition of the programmed death protein 1 immune checkpoint and the development of heart failure in the presence of prior cardiac ischaemia
ESC Journals
Inhibition of the programmed death protein 1 immune checkpoint and the development of heart failure in the presence of prior cardiac ischaemia
22 April 2026
See more
Differential effects of semaglutide and colchicine on atrial remodeling in rats with reduced ejection fraction after myocardial infarction
ESC Journals
Differential effects of semaglutide and colchicine on atrial remodeling in rats with reduced ejection fraction after myocardial infarction
21 April 2026
See more
Reperfusion in ST-elevation myocardial infarction in low- and middle-income countries: setting priorities, not lowering standards
ESC Journals
Reperfusion in ST-elevation myocardial infarction in low- and middle-income countries: setting priorities, not lowering standards
15 April 2026
See more
Fat, muscle, and anti-obesity medications in cardiovascular disease prevention
ESC Journals
Fat, muscle, and anti-obesity medications in cardiovascular disease prevention
31 March 2026
See more
Development and validation of clinical prediction models for personalized renal function monitoring in people with heart failure in primary care: the RENAL-HF study protocol
ESC Journals
Development and validation of clinical prediction models for personalized renal function monitoring in people with heart failure in primary care: the RENAL-HF study protocol
31 March 2026
See more
Antithrombotic therapy for secondary prevention in patients with acute coronary syndromes treated with percutaneous coronary intervention: options for personalization to reduce bleeding or ischaemic risks A Clinical Consensus Statement of the ESC Working Group on Thrombosis, the Association for Acute CardioVascular Care of the ESC, the European Association of Percutaneous Cardiovascular Interventions of the ESC, and the ESC Working Group on Cardiovascular Pharmacology
ESC Journals
Antithrombotic therapy for secondary prevention in patients with acute coronary syndromes treated with percutaneous coronary intervention: options for personalization to reduce bleeding or ischaemic risks A Clinical Consensus Statement of the ESC Working Group on Thrombosis, the Association for Acute CardioVascular Care of the ESC, the European Association of Percutaneous Cardiovascular Interventions of the ESC, and the ESC Working Group on Cardiovascular Pharmacology
31 March 2026
See more
Troponin T/I discordance in immune checkpoint inhibitor myositis in a patient with ischaemic cardiac disease: a case report
ESC Journals
Troponin T/I discordance in immune checkpoint inhibitor myositis in a patient with ischaemic cardiac disease: a case report
18 March 2026
See more
Efficacy of ranolazine in reducing complex premature ventricular contractions in a patient with mitral valve prolapse: a case report
ESC Journals
Efficacy of ranolazine in reducing complex premature ventricular contractions in a patient with mitral valve prolapse: a case report
18 March 2026
See more
VEGF-C-mediated cardiac lymphangiogenesis promotes inflammation resolution in autoimmune acute myocarditis in mice
ESC Journals
VEGF-C-mediated cardiac lymphangiogenesis promotes inflammation resolution in autoimmune acute myocarditis in mice
17 March 2026
See more

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources